| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.38B | 14.18B | 14.49B | 20.03B | 15.84B | 10.04B |
| Gross Profit | 3.89B | 3.07B | 2.44B | 6.51B | 5.22B | 2.24B |
| EBITDA | 3.18B | 2.37B | 1.87B | 4.62B | 3.81B | 1.58B |
| Net Income | 1.28B | 810.80M | 707.79M | 3.86B | 2.07B | 772.17M |
Balance Sheet | ||||||
| Total Assets | 22.13B | 20.94B | 21.95B | 24.64B | 21.60B | 17.12B |
| Cash, Cash Equivalents and Short-Term Investments | 3.77B | 2.75B | 3.13B | 5.45B | 5.25B | 4.43B |
| Total Debt | 70.56M | 26.44M | 32.05M | 43.63M | 664.26M | 1.95B |
| Total Liabilities | 3.51B | 3.47B | 5.01B | 6.15B | 5.96B | 6.59B |
| Stockholders Equity | 12.98B | 12.11B | 14.79B | 16.08B | 13.12B | 8.54B |
Cash Flow | ||||||
| Free Cash Flow | 309.32M | 278.14M | -536.56M | 1.24B | -43.38M | 525.19M |
| Operating Cash Flow | 1.66B | 2.07B | 1.38B | 5.08B | 3.91B | 2.26B |
| Investing Cash Flow | -1.32B | -1.50B | -2.63B | -2.91B | -4.09B | -1.96B |
| Financing Cash Flow | -192.98M | -648.37M | -1.51B | -1.96B | 999.52M | 1.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$10.94B | 51.28 | 5.86% | ― | 29.64% | -3.91% | |
73 Outperform | HK$4.47B | 7.86 | 9.36% | 6.70% | -3.73% | 6.09% | |
62 Neutral | HK$18.81B | 13.61 | 10.43% | 0.98% | -1.43% | 113.67% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | HK$1.18B | 16.45 | 3.61% | 2.20% | -8.51% | -68.34% | |
56 Neutral | HK$4.20B | 5.57 | 13.87% | ― | 9.20% | 213.87% | |
54 Neutral | HK$10.11B | -142.77 | -0.52% | 1.16% | -15.17% | -125.24% |
Dongyue Group Limited has reshaped the composition of its nomination committee by appointing executive director Ms. Chung Tak Lai and independent non-executive director Mr. Ma Zhizhong as members, effective 31 December 2025. The committee now includes a director of a different gender while maintaining a majority of independent non-executive directors, aligning the company with the amended Corporate Governance Code of the Hong Kong Stock Exchange; the board expects these changes, together with updated terms of reference for the committee, to strengthen board diversity, enhance effectiveness, and further improve overall corporate governance practices.
The most recent analyst rating on (HK:0189) stock is a Hold with a HK$11.50 price target. To see the full list of analyst forecasts on Dongyue Group Limited stock, see the HK:0189 Stock Forecast page.
Dongyue Group Limited has announced the current composition of its board of directors, led by Chairman and Chief Executive Officer Zhang Jianhong, President Wang Weidong and Vice President and Chief Financial Officer Zhang Zhefeng, supported by one additional executive director and three independent non-executive directors. The company has also detailed the membership of its five key board committees—Audit, Remuneration, Nomination, Corporate Governance and Risk Management—underscoring a delineated governance and oversight structure that places independent directors in pivotal monitoring roles, a move that reinforces compliance with corporate governance best practices and may reassure investors about the robustness of its risk control, remuneration oversight and board appointment processes.
The most recent analyst rating on (HK:0189) stock is a Hold with a HK$11.50 price target. To see the full list of analyst forecasts on Dongyue Group Limited stock, see the HK:0189 Stock Forecast page.
Dongyue Group Limited has revised and adopted updated terms of reference for its Nomination Committee, effective 31 December 2025, formalizing the committee’s constitution, membership requirements, and meeting procedures. The new terms emphasize a majority of independent non-executive directors, gender diversity within the committee, and clear authority to obtain external professional advice, while assigning duties that include annual reviews of board composition and skills, identification and recommendation of director candidates, assessment of director independence, succession planning for key leadership roles, regular board performance evaluations, and oversight of board diversity policies and related disclosures, reinforcing the company’s corporate governance framework and transparency to shareholders.
The most recent analyst rating on (HK:0189) stock is a Hold with a HK$11.50 price target. To see the full list of analyst forecasts on Dongyue Group Limited stock, see the HK:0189 Stock Forecast page.
Dongyue Group Limited announced the quarterly results of its subsidiary, Shandong Dongyue Organosilicon Materials Co. Ltd., for the third quarter of 2025. The subsidiary reported unaudited financials, including a total asset value of RMB 6,072,803, revenue of RMB 3,026,685, and a net profit of RMB 2,857. The results highlight the company’s financial status but caution is advised as the figures are unaudited.
The most recent analyst rating on (HK:0189) stock is a Hold with a HK$11.50 price target. To see the full list of analyst forecasts on Dongyue Group Limited stock, see the HK:0189 Stock Forecast page.
Dongyue Group Limited announced that its subsidiary, Shandong Dongyue Organosilicon Materials Co. Ltd., expects a significant decrease in net profit for the first three quarters of 2025, with estimates showing a drop of approximately 96.27% to 97.40% year-on-year. This substantial decline in profitability highlights potential challenges in the market or operational difficulties, urging shareholders and investors to exercise caution when dealing with the company’s securities.
The most recent analyst rating on (HK:0189) stock is a Hold with a HK$13.00 price target. To see the full list of analyst forecasts on Dongyue Group Limited stock, see the HK:0189 Stock Forecast page.